Aprea Therapeutics, Inc. Common stock
$0.905
USD
Last updated on --.
24h volume50.69K
24h highest0.94000 USD
24h lowest0.89500 USD
24h Price movement-0.55%
APRE recent prices
24 Hours
-0.55%-$0.005
30 days
+7.54%+$0.0631
60 days
+21.79%+$0.161
90 days
-1.82%-$0.0167
Key data
Previous close0.91000 USD
Market cap11.14M USD
Volume50.69K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.97000 USD
Net income (FY)-11.95M USD
Revenue (FY)123.30K USD
Last report dateMay 13, 2026
About Aprea Therapeutics, Inc. Common stock
HeadquartersDOYLESTOWN
Employees (FY)8.00
Revenue per employee (FY)15.41K USD
Net income per employee (FY)-1.49M USD
Listed onNasdaq
APRE conversion tables
 |  |
|---|---|
| 0.5 APRE | 0.4525 USD |
| 1 APRE | 0.905 USD |
| 5 APRE | 4.525 USD |
| 10 APRE | 9.050 USD |
| |
|---|---|
| 0.5 USD | 0.55249 APRE |
| 1 USD | 1.104 APRE |
| 5 USD | 5.524 APRE |
| 10 USD | 11.04 APRE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
APRE is trading at $0.905, -0.55% over the last 24 hours. Track live moves on the price chart at the top of this page.
The APRE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. APRE is currently trading at $0.905, -0.55% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on APRE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. APRE's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from APRE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against APRE's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Aprea Therapeutics, Inc. Common stock's market cap is currently 11.14M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume50.69K
24h highest0.94000 USD
24h lowest0.89500 USD
24h Price movement-0.55%
Start trade with APRE Perpetual
Sign up to trade